Ann Gastroenterol. 2016 Jul-Sep;29(3):312-7. doi: 10.20524/aog.2016.0045. Epub 2016 May 20.
Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review.
Annals of gastroenterology
Rubayat Rahman, Douglas L Nguyen, Umair Sohail, Ashraf A Almashhrawi, Imran Ashraf, Srinivas R Puli, Matthew L Bechtold
Affiliations
Affiliations
- Division of Gastroenterology and Hepatology, University of Missouri Health Sciences Center (Rubayat Rahman, Umair Sohail, Ashraf A. Almashhrawi, Imran Ashraf, Matthew L. Bechtold), USA.
- Gastroenterology and Hepatology, University of California-Irvine (Douglas L. Nguyen), USA.
- Gastroenterology and Hepatology, University of Illinois-Peoria (Srinivas R. Puli), USA.
PMID: 27366031
PMCID: PMC4923816 DOI: 10.20524/aog.2016.0045
Abstract
BACKGROUND: In patients suffering from upper gastrointestinal bleeding (UGIB), adequate visualization is essential during endoscopy. Prior to endoscopy, erythromycin administration has been shown to enhance visualization in these patients; however, guidelines have not fully adopted this practice. Thus, we performed a comprehensive, up-to-date meta-analysis on the issue of erythromycin administration in this patient population.
METHODS: After searching multiple databases (November 2015), randomized controlled trials on adult subjects comparing administration of erythromycin before endoscopy in UGIB patients to no erythromycin or placebo were included. Pooled estimates of adequacy of gastric mucosa visualized, need for second endoscopy, duration of procedure, length of hospital stay, units of blood transfused, and need for emergent surgery using odds ratio (OR) or mean difference (MD) were calculated. Heterogeneity and publication bias were assessed.
RESULTS: Eight studies (n=598) were found to meet the inclusion criteria. Erythromycin administration showed statistically significant improvement in adequate gastric mucosa visualization (OR 4.14; 95% CI: 2.01-8.53, P<0.01) while reduced the need for a second-look endoscopy (OR 0.51; 95% CI: 0.34-0.77, P<0.01) and length of hospital stay (MD -1.75; 95% CI: -2.43 to -1.06, P<0.01). Duration of procedure (P=0.2), units of blood transfused (P=0.08), and need for emergent surgery (P=0.88) showed no significant differences.
CONCLUSION: Pre-endoscopic erythromycin administration in UGIB patients significantly improves gastric mucosa visualization while reducing length of hospital stay and the need for second-look endoscopy.
Keywords: Erythromycin; bleeding; endoscopy
References
- Ann Emerg Med. 2011 Jun;57(6):582-9 - PubMed
- Ann Intern Med. 2010 Jan 19;152(2):101-13 - PubMed
- Wiad Lek. 2006;59(7-8):490-1 - PubMed
- Gastrointest Endosc. 2002 Aug;56(2):174-9 - PubMed
- J Clin Gastroenterol. 2004 Nov-Dec;38(10):861-5 - PubMed
- Gastroenterol Hepatol Bed Bench. 2013 Fall;6(4):195-201 - PubMed
- J Nucl Med. 1990 Sep;31(9):1490-3 - PubMed
- Gastrointest Endosc. 2011 Feb;73(2):245-50 - PubMed
- Gastrointest Endosc. 2011 Jul;74(1):234; author reply 234-5 - PubMed
- Gastrointest Endosc. 2012 Jun;75(6):1132-8 - PubMed
- Am J Gastroenterol. 2012 Mar;107(3):345-60; quiz 361 - PubMed
- Scand J Gastroenterol. 2011 Jul;46(7-8):920-4 - PubMed
- Intensive Care Med. 2005 Jul;31(7):949-54 - PubMed
- Am J Gastroenterol. 2006 Jun;101(6):1211-5 - PubMed
- Gastrointest Endosc. 1997 Aug;46(2):105-12 - PubMed
- Saudi J Gastroenterol. 2013 Sep-Oct;19(5):205-10 - PubMed
- Gastroenterology. 2002 Jul;123(1):17-23 - PubMed
- Gastrointest Endosc. 2010 Dec;72(6):1138-45 - PubMed
- Aliment Pharmacol Ther. 2011 Jul;34(2):166-71 - PubMed
- Endoscopy. 2015 Oct;47(10):a1-46 - PubMed
Publication Types